A quinoxaline-based compound ameliorates bone loss in ovariectomized mice.


Journal

Experimental biology and medicine (Maywood, N.J.)
ISSN: 1535-3699
Titre abrégé: Exp Biol Med (Maywood)
Pays: England
ID NLM: 100973463

Informations de publication

Date de publication:
12 2021
Historique:
pubmed: 27 7 2021
medline: 28 12 2021
entrez: 26 7 2021
Statut: ppublish

Résumé

DMB (6,7-dichloro-2-methylsulfonyl-3-Ntert-butylaminoquinoxaline) is a quinoxaline-based compound that has been investigated as a glucagon-like peptide-1 receptor (GLP-1R) agonist. To clarify anti-osteoporosis effect of DMB, an osteoporotic mice model was established by ovariectomy (OVX) operation. The OVX mice were given intraperitoneally DMB, exendin-4 (EX-4), or 17β-estradiol (E

Identifiants

pubmed: 34308655
doi: 10.1177/15353702211032133
pmc: PMC8649934
doi:

Substances chimiques

Glucagon-Like Peptide-1 Receptor 0
Quinoxalines 0
Glucagon-Like Peptide 1 89750-14-1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2502-2510

Références

Diabetes Metab Syndr. 2019 Jul - Aug;13(4):2607-2612
pubmed: 31405683
Diabetes. 2010 Dec;59(12):3099-107
pubmed: 20823098
Subcell Biochem. 2019;91:453-476
pubmed: 30888662
J Endocrinol. 2011 May;209(2):203-10
pubmed: 21372151
Front Endocrinol (Lausanne). 2019 Feb 26;10:75
pubmed: 30863364
Front Psychiatry. 2019 Jan 28;9:781
pubmed: 30745885
J Clin Invest. 2005 Dec;115(12):3318-25
pubmed: 16322775
Diabetologia. 2013 Sep;56(9):1878-83
pubmed: 23748861
PLoS One. 2014 Sep 02;9(9):e105683
pubmed: 25180755
J Endocrinol. 2018 Jan;236(1):R29-R42
pubmed: 28855317
Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):937-42
pubmed: 17213325
Biochem Biophys Res Commun. 2012 Jan 6;417(1):558-63
pubmed: 22177947
J Biol Chem. 2008 Mar 28;283(13):8723-35
pubmed: 18216022
Acta Pharmacol Sin. 2012 Feb;33(2):148-54
pubmed: 22301855
JBMR Plus. 2019 Aug 23;3(10):e10209
pubmed: 31687645
Endocrinology. 2011 Jan;152(1):1-3
pubmed: 21183707
Sci Rep. 2016 Mar 22;6:23367
pubmed: 27000963
Regul Pept. 2010 Jan 8;159(1-3):61-6
pubmed: 19586609
Oncotarget. 2017 Dec 27;9(7):7372-7388
pubmed: 29484117
J Bone Miner Res. 2013 Jul;28(7):1641-52
pubmed: 23427056
Drug Discov Today. 2005 Mar 15;10(6):417-27
pubmed: 15808821
Life Sci. 2013 Mar 21;92(10):533-40
pubmed: 23357248
Ann Transl Med. 2019 Aug;7(16):369
pubmed: 31555683
Endocrine. 2015 Feb;48(1):107-15
pubmed: 25074632
PLoS One. 2014 Apr 02;9(4):e93746
pubmed: 24695667
PLoS One. 2016 Feb 10;11(2):e0148827
pubmed: 26863436
Biochem Biophys Res Commun. 2019 Aug 13;516(1):300-306
pubmed: 31256933
Pharmacol Rev. 2016 Oct;68(4):954-1013
pubmed: 27630114
Front Endocrinol (Lausanne). 2017 May 03;8:98
pubmed: 28515711
Int J Mol Sci. 2018 Aug 28;19(9):
pubmed: 30154383
BMC Musculoskelet Disord. 2019 Nov 13;20(1):532
pubmed: 31722698
Int J Neurosci. 2021 May 3;:1-38
pubmed: 33941038
Sci Rep. 2019 Sep 20;9(1):13651
pubmed: 31541189
J Bone Miner Metab. 2019 May;37(3):563-572
pubmed: 30238428
Endocrinology. 2011 Aug;152(8):3103-12
pubmed: 21693680
J Bone Miner Res. 1996 Mar;11(3):337-49
pubmed: 8852944
Arch Osteoporos. 2020 Feb 24;15(1):26
pubmed: 32095898
Exp Ther Med. 2018 Jun;15(6):5077-5083
pubmed: 29805533
DNA Cell Biol. 2018 Dec;37(12):1031-1043
pubmed: 30403540
Curr Diab Rep. 2016 Dec;16(12):120
pubmed: 27766579
PLoS One. 2015 Jul 15;10(7):e0132744
pubmed: 26177280
Physiol Behav. 2010 Feb 9;99(2):175-80
pubmed: 19555704
Eur J Pharmacol. 2010 Feb 25;628(1-3):268-73
pubmed: 19917278
ChemMedChem. 2018 Apr 6;13(7):662-671
pubmed: 29430842
Bone Res. 2018 Jun 14;6:19
pubmed: 29928541
J Bone Miner Metab. 2015 Nov;33(6):658-65
pubmed: 25300746

Auteurs

Ying Zhou (Y)

Department of Basic Medicine, Xi'an Medical University, Xi'an 710021, PR China.
Science and Technology Innovation Platform of Shaanxi Provincial Research Center for Project of Prevention and Treatment of Respiratory Diseases, Xi'an Medical University, Xi'an 710021, PR China.

Xiaoyan Xue (X)

Department of Pharmacology, School of Pharmacy, the Fourth Military Medical University, Xi'an 710032, PR China.

Yanyan Guo (Y)

Precision Pharmacy & Drug Development Center, Department of Pharmacy, Tangdu Hospital, the Fourth Military Medical University, Xi'an 710038, PR China.

Huan Liu (H)

Department of Basic Medicine, Xi'an Medical University, Xi'an 710021, PR China.

Zheng Hou (Z)

Department of Pharmacology, School of Pharmacy, the Fourth Military Medical University, Xi'an 710032, PR China.

Zhou Chen (Z)

Department of Pharmacology, School of Pharmacy, the Fourth Military Medical University, Xi'an 710032, PR China.

Ning Wang (N)

Department of Pharmacology, School of Pharmacy, the Fourth Military Medical University, Xi'an 710032, PR China.

Fen Li (F)

Department of Basic Medicine, Xi'an Medical University, Xi'an 710021, PR China.

Yang Wang (Y)

Department of Basic Medicine, Xi'an Medical University, Xi'an 710021, PR China.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH